205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.61%
Revenue growth above 1.5x NXPI's 3.93%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.90%
Gross profit growth above 1.5x NXPI's 4.38%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
22.28%
EBIT growth above 1.5x NXPI's 10.74%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
24.52%
Operating income growth above 1.5x NXPI's 10.74%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
20.85%
Net income growth above 1.5x NXPI's 9.12%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
20.33%
EPS growth above 1.5x NXPI's 9.30%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
20.49%
Diluted EPS growth above 1.5x NXPI's 9.84%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.11%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.11%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.06%
Dividend growth under 50% of NXPI's 4.77%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
10.25%
OCF growth above 1.5x NXPI's 3.24%. David Dodd would confirm a clear edge in underlying cash generation.
-17.95%
Negative FCF growth while NXPI is at 9.77%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
37.66%
10Y revenue/share CAGR under 50% of NXPI's 98.20%. Michael Burry would suspect a lasting competitive disadvantage.
12.73%
5Y revenue/share CAGR under 50% of NXPI's 57.37%. Michael Burry would suspect a significant competitive gap or product weakness.
-9.62%
Negative 3Y CAGR while NXPI stands at 19.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
45.40%
10Y OCF/share CAGR at 50-75% of NXPI's 81.29%. Martin Whitman might fear a structural deficiency in operational efficiency.
-10.96%
Negative 5Y OCF/share CAGR while NXPI is at 14.53%. Joel Greenblatt would question the firm’s operational model or cost structure.
-27.88%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
91.44%
Below 50% of NXPI's 448.23%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-2.12%
Negative 5Y net income/share CAGR while NXPI is 622.44%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-29.28%
Negative 3Y CAGR while NXPI is 44.92%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
91.46%
Below 50% of NXPI's 1382.98%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
96.82%
5Y equity/share CAGR above 1.5x NXPI's 9.86%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
43.67%
3Y equity/share CAGR similar to NXPI's 46.23%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
332.01%
Dividend/share CAGR of 332.01% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
68.60%
Below 50% of NXPI's 321.68%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
27.39%
Below 50% of NXPI's 85.48%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
8.83%
AR growth well above NXPI's 15.43%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.63%
Inventory growth well above NXPI's 4.00%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.78%
Asset growth well under 50% of NXPI's 2.04%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.20%
Under 50% of NXPI's 4.69%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.92%
Debt growth far above NXPI's 0.02%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-1.20%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.96%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.